Mr Sinha is Chief Financial Officer and co-founder of ElevateBio, a holding company focused on building cell and gene therapy companies, which was formed in January 2018. He also serves as President and Chief Financial Officer of AlloVir, an ElevateBio portfolio company. From 2005 to 2016, he was the Chief Financial Officer of Alexion Pharmaceuticals, a biotechnology company. Mr Sinha holds a master's degree in business administration from the Asian Institute of Management. He is also a qualified Chartered Accountant from the Institute of Chartered Accountants of India and a Certified Public Accountant in the US.